Trials / Not Yet Recruiting
Not Yet RecruitingNCT07221656
Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the median duration of therapeutic serum asparaginase activity (SAA) levels after administration of calaspargase pegol (Cal-PEG) and the potential association between peak SAA levels and duration of therapeutic levels with toxicity in pediatric patients with acute lymphoblastic leukemia or lymphoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional Study | Non-interventional study |
Timeline
- Start date
- 2027-02-01
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
- First posted
- 2025-10-28
- Last updated
- 2026-04-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07221656. Inclusion in this directory is not an endorsement.